Sapatnekar, A. (2025) “ Conventional Synthetic Disease-modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India”, Journal of the Diabetic Association of India, 1(1). Available at: https://journals.onemd.in/index.php/jdai/article/view/59 (Accessed: 18 July 2025).